/MD

Pediatrix Medical Group Inc

MD

$26.77USD↑+0.15%+0.04 today

MARKET CAP

2.2B

P/E (TTM)

13.0x

FWD P/E

—

DAY RANGE

$27 – $27

52W RANGE

$16

$28

AI Summary

Stalk

StalkMedium

MD remains in a Stage 2 uptrend with higher highs & higher lows, trading in a tight range above the 9/20 EMA stack. The medium-term bias is firmly bullish based on structural continuation, but short-term timing is neutral. Stalk pullbacks into the 9/20 EMA zone for a higher-probability entry.

↑Q2 adjusted EBITDA $76M; revenue +4% YoY, 2% same-unit growth
↑Building tele-hybrid model, expanding telemedicine services nationwide
↓NICU days down 3% and same-unit volumes -2% signal patient decline

Full analysis →

Buying

6

institutions

Selling

5

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	13.71 M	347.38 M	+139.90 K	+19.6%	0.01%
RC Rockefeller Capital Management L.P. Q2 2026	BUY	1.34 M	33.91 M	+576.10 K	+107.9%	0.05%
RT Renaissance Technologies LLC Q2 2026	SELL	1.29 M	32.61 M	+-245.00 K	-0.5%	0.05%
AC Aqr Capital Management LLC Q2 2026	SELL	471.29 K	11.53 M	+-89.28 K	-3.9%	0.00%
JC Jpmorgan Chase & Co Q2 2026	SELL	209.89 K	5.27 M	+-23.06 K	+8.8%	0.00%
JH Janus Henderson Group Plc Q1 2026	BUY	68.53 K	1.47 M	+34.26 K	+100.0%	0.00%
MM Millennium Management LLC Q2 2026	BUYNEW	55.12 K	1.40 M	+55.12 K	+0.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUY	13.07 K	331.06 K	+3.49 K	+61.5%	0.00%
GM Grantham, Mayo, Van Otterloo & Co. LLC Q2 2026	BUY	10.99 K	278.50 K	+1.30 K	+34.3%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	0.00	0.00	+-73.00 K	-100.0%	0.00%
BA Balyasny Asset Management L.P. Q2 2026	SELL	0.00	0.00	+-10.86 K	-100.0%	0.00%